Our recent investigation suggests that modification of the alcoholic hydroxyl group at C-23 of 3,5,7,20-O-tetramethyl-2,3-dehydrosilybin resulted in appreciably higher selectivity in suppressing AR-positive LNCaP prostate cancer cell proliferation compared with modification of the phenolic hydroxyl groups [27]. The gene discussed is AR; the disease is prostate cancer.